The human papillomavirus (HPV) vaccine has been touted as a way to prevent cervical cancer and genital warts, but a new study suggests the vaccine may also prevent women diagnosed with precancers from developing recurrences.
Researchers randomly assigned more than 1,350 women diagnosed with genital warts or certain precancerous conditions to receive either three injections of the HPV vaccine or a placebo. The women were followed for about four years.
Women who received the vaccine had 46.2 percent lower risk of developing another HPV-related disease after treatment for their genital warts or their precancerous condition.
Typically, women treated for these types of conditions are at risk for subsequent disease later, but the study offers evidence that “vaccination offered substantial benefit” in terms of lowering that risk, wrote the international team of authors, led by Elmar Joura, an associate professor at the University of Vienna in Austria.
Experts not involved with the research told ABC News that the research is significant because it suggests for the first time that the HPV vaccine may offer benefits beyond prevention.
A new urine test can help aid early detection of and treatment decisions about prostate cancer, a study from the University of Michigan Comprehensive Cancer Center and the Michigan Center for Translational Pathology finds.
The test supplements an elevated prostate specific antigen, or PSA, screening result, and could help some men delay or avoid a needle biopsy while pointing out men at highest risk for clinically significant prostate cancer.
The test looks for a genetic anomaly that occurs in about half of all prostate cancers, an instance of two genes changing places and fusing together. This gene fusion, TMPRSS2:ERG, is believed to cause prostate cancer. Studies in prostate tissues show that the gene fusion almost always indicates cancer. But because the gene fusion is present only half the time, the researchers also included another marker, PCA3. The combination was more predictive of cancer than either marker alone.
SEATTLE — Caffeine may do more than just help you wake up each morning. According to a study published Monday in the Proceedings of the National Academy of Sciences, it can also guard against certain skin cancers.
Researchers at both the University of Washington and Rutgers University say caffeine inhibits a DNA repair pathway, helping kill cells damaged by the sun.
Experts suggest that moderate caffeine drinking, or caffeine based lotion, could be useful in preventing skin cancer.
- U.S. cancer death rates continue to drop
- Lung cancer likely to overtake breast cancer as the main cause of cancer death among European women
- Squeezing Breasts Can Help Fight Breast Cancer
- Enzyme offers new therapeutic target for cancer drugs
- HPV Vaccine May Prevent Recurrence of Precancerous Conditions
- Survival Rate of Cancer Patients in Korea Ranked in the Top in the World
- Kids’ leukemia risk raised by dads who smoke
- Transplant recipients have a high risk of developing cancer
- CDC recommends that boys get vaccinated against HPV
- Cancer survivor population over 65 to increase over next decade